Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- DXB.AU
- Price
- 0.60
- Stock movement down
- -0.02 (-3.23%)
- Company name
- Dimerix Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 360.24M
- Ent value
- 369.75M
- Price/Sales
- 59.31
- Price/Book
- 26.92
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 14.29%
- 1 year return
- 71.43%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-12
DIVIDENDS
DXB.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 16.17 |
| Price to FCF | 16.02 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 59.31 |
| Price to Book | 26.92 |
| EV to Sales | 60.88 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 600.40M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 68.28M |
| Net receivables | 3.64M |
| Total current assets | 72.18M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 407.36K |
| Total assets | 91.18M |
| Accounts payable | 14.08M |
| Short/Current long term debt | 97.48K |
| Total current liabilities | 22.16M |
| Total liabilities | 77.80M |
| Shareholder's equity | 13.38M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.60 |
| Daily high | 0.63 |
| Daily low | 0.59 |
| Daily Volume | 1.26M |
| All-time high | 65.90 |
| 1y analyst estimate | 0.84 |
| Beta | 0.17 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 24 Sep 1999 |
| Next earnings date | 23 Feb 2026 |
Downside potential
Loading...
Downside potential data
| DXB.AU | S&P500 | |
| Current price drop from All-time high | -99.09% | -1.08% |
| Highest price drop | -99.53% | -19.00% |
| Date of highest drop | 24 Dec 2024 | 8 Apr 2025 |
| Avg drop from high | -99.27% | -2.64% |
| Avg time to new high | - | 6 days |
| Max time to new high | 300 days | 89 days |
COMPANY DETAILS
Marketcap
360.24M
Marketcap category
Small-cap
Description
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is headquartered in Fitzroy, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found